Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology

March 2023 in “ Arabian Journal of Chemistry ”

Feifei Sun, Jinde Liu, Tariq Ali, Zhonglei Wang, Yongning Wu, Lin Li

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on arabjchem.org →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Evaluating Cepharanthine Analogues as Natural Drugs Against SARS-CoV-2

29 citations , November 2021 in “FEBS Open Bio”

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Comparison of Viral RNA–Host Protein Interactomes Across Pathogenic RNA Viruses Informs Rapid Antiviral Drug Discovery for SARS-CoV-2

research Comparison of Viral RNA–Host Protein Interactomes Across Pathogenic RNA Viruses Informs Rapid Antiviral Drug Discovery for SARS-CoV-2

100 citations , November 2021 in “Cell Research”

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

research Cepharanthine: A Review of the Antiviral Potential of a Japanese-Approved Alopecia Drug in COVID-19

70 citations , July 2020 in “Pharmacological Reports”

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.